The Ensign Group, Inc. ENSG recently announced a series of strategic acquisitions across Washington and California. These acquisitions, effective April 1, 2025, underscore the company’s commitment to...
CEO Adam Grossman highlighted a 65% year-over-year jump in total revenue and a staggering 309% increase in adjusted EBITDA for 2024.
We expect investors to focus on the sales performance of ADMA Biologics’ ADMA portfolio of marketed products and other pipeline updates when it reports fourth-quarter 2024 results.See the Zacks Earnings...
From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.
Biotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025.